The Fight Against HIV Falters As Infection Rates Climb

More than four decades have elapsed since the CDC identified the initial HIV cases in the United States. Throughout this time, we have experienced remarkable advancements in science and medicine—innovations that were once thought impossible. These milestones stem from the collaboration of individuals living with HIV, healthcare professionals, advocates, government entities, and the communities deeply affected by the epidemic.Today, we are on the brink of eradicating HIV. However, escalating infection rates—especially among Black and Latine populations—pose a significant hurdle to this aspiration. Early in the epidemic, individuals had a life expectancy of just two to ten years post-diagnosis. Nowadays, due to enhanced access to antiretroviral therapy (ART), many individuals over 50 are living with HIV. Moreover, prevention strategies have evolved significantly. In response, the CDC recently endorsed a biannual injectable PrEP option, enhancing HIV prevention opportunities, particularly for those facing accessibility challenges in underserved communities. Despite remarkable strides, stigma and insufficient awareness remain critical obstacles, compounding disparities across affected demographics. As a result, collective action from providers and communities remains vital in overcoming these barriers and ensuring equitable access to necessary care.